Weighted Average Number of Shares Outstanding, Basic of CAPRICOR THERAPEUTICS, INC. from 2016 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
CAPRICOR THERAPEUTICS, INC. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from 2016 to Q3 2025.
  • CAPRICOR THERAPEUTICS, INC. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 45.7M shares, a 38.2% increase year-over-year.
  • CAPRICOR THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 35.2M shares, a 31.5% increase from 2023.
  • CAPRICOR THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 26.8M shares, a 9.07% increase from 2022.
  • CAPRICOR THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 24.6M shares, a 6.34% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

CAPRICOR THERAPEUTICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 45.7M +12.6M +38.2% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 45.7M +13.9M +43.6% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 45.6M +14.3M +45.6% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 35.2M +8.44M +31.5% 01 Oct 2024 31 Dec 2024 10-K 26 Mar 2025
Q3 2024 33.1M +7.27M +28.2% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 31.8M +6.51M +25.7% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025
Q1 2024 31.4M +6.11M +24.2% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 26.8M +2.23M +9.07% 01 Oct 2023 31 Dec 2023 10-K 26 Mar 2025
Q3 2023 25.8M +1.39M +5.67% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 25.3M +1.01M +4.16% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 25.2M +965K +3.97% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 24.6M +1.46M +6.34% 01 Oct 2022 31 Dec 2022 10-K 11 Mar 2024
Q3 2022 24.4M +1.34M +5.79% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 24.3M +1.46M +6.4% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 24.3M +2.05M +9.24% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 23.1M 01 Oct 2021 31 Dec 2021 10-K 17 Mar 2023
Q3 2021 23.1M +3.29M +16.6% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 22.9M +7.73M +51.1% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 22.2M 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q3 2020 19.8M 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 15.1M 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021

CAPRICOR THERAPEUTICS, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 35.2M +8.44M +31.5% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025
2023 26.8M +2.23M +9.07% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025
2022 24.6M +1.46M +6.34% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2024
2021 23.1M +7.52M +48.3% 01 Jan 2021 31 Dec 2021 10-K 17 Mar 2023
2020 15.6M +11.9M +320% 01 Jan 2020 31 Dec 2020 10-K 11 Mar 2022
2019 3.71M +770K +26.2% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2021
2018 2.94M -20.3M -87.3% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020
2017 23.2M +4.64M +25% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
2016 18.6M 01 Jan 2016 31 Dec 2016 10-K 22 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.